Magnendo develops AI-powered endoscopy and robotics technologies for gastrointestinal disease detection, diagnosis, and clinical support.
Magnendo has raised $18.0M in total funding. The most recent round was Series A. The last funding was announced in July 2026.
Magnendo's investors include Kakao Ventures, Penumbra, Bass Investment, SBXi.
Magnendo is headquartered in Newton, United States.
Magnendo develops AI-powered endoscopy and robotics technologies for gastrointestinal disease detection, diagnosis, and clinical support.
Magnendo is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Magnendo — Funding & Investors." VCBacked, July 24, 2026, https://www.vcbacked.co/company/magnendo. Accessed October 30, 2026.
VCBacked. (2026). Magnendo — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/magnendo
{{cite web |title=Magnendo — Funding & Investors |url=https://www.vcbacked.co/company/magnendo |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated